1. Jouneau S, Vauléon E, Caulet-Maugendre S, et al. 2011;
131I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases. Chest. 139:1463–1469. DOI:
10.1378/chest.10-1591. PMID:
20947651.
2. Kim S, Kim HY, Lee SL, Ku YM, Won YD, Kim CW. 2020; Lipiodol pneumonitis following transcatheter arterial chemoembolization for hepatocellular carcinoma. J Liver Cancer. 20:60–66. DOI:
10.17998/jlc.20.1.60.
Article
3. Youn I, Chong S, Kwak BK, et al. 2011; Pulmonary lipiodol accumulation after transarterial chemoembolization: CT findings and its radiologic outcomes. J Korean Soc Radiol. 65:577–583. DOI:
10.3348/jksr.2011.65.6.577.
Article
4. Xia J, Ren Z, Ye S, et al. 2006; Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol. 59:407–412. DOI:
10.1016/j.ejrad.2006.03.002. PMID:
16621394.
Article
5. Chung JW, Park JH, Im JG, Han JK, Han MC. 1993; Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 187:689–693. DOI:
10.1148/radiology.187.3.8388567. PMID:
8388567.
Article
6. Tajima T, Honda H, Kuroiwa T, et al. 2002; Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. J Vasc Interv Radiol. 13:893–900. DOI:
10.1016/S1051-0443(07)61772-2. PMID:
12354823.
Article
8. Lee JH, Won JH, Park SI, Won JY, Lee DY, Kang BC. 2007; Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein. J Vasc Interv Radiol. 18:377–382. DOI:
10.1016/j.jvir.2007.01.005. PMID:
17377183.
Article